TITLE:
A Rheumatoid Arthritis (RA) Study Treating Signs and Symptoms of RA in People With RA & Receiving Methotrexate

CONDITION:
Rheumatoid Arthritis

INTERVENTION:
Placebo

SUMMARY:

      This clinical study is investigating AMG 719, an investigational drug, for the treatment of
      patients who have Rheumatoid Arthritis and who are taking Methotrexate. AMG 719 is a drug
      which is self-injected beneath the skin (similarly to the way insulin is self-injected by
      diabetics). Patients on this study are on study for 28-weeks. They visit the study facility
      at least 11 times while participating in the study.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 18 Years to N/A
Criteria:

        -  Men or women, at least 18 years of age at screening

          -  Diagnosed with Rheumatoid Arthritis, with a disease duration of at least 24 weeks,
             receiving methotrexate, and having no recent history of substance or alcohol abuse
      
